The effects of chlorhexidine gluconate bathing on health care-associated infection in intensive care units: A meta-analysis

Journal of Critical Care

Volumn 32, Issue , 2016, Pages 126-137

  Kim, Ha Yeon ^a   Lee, Woo Kyung ^a   Na, Sungwon ^a   Roh, Yun Ho ^a   Shin, Cheung Soo ^a   Kim, Jeongmin ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Chlorhexidine bathing; Health care associated infection; Meta analysis; Risk ratio

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; PSEUDOMONIC ACID; CHLORHEXIDINE; DISINFECTANT AGENT;

BATH; CATHETER INFECTION; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; HEALTHCARE ASSOCIATED INFECTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANALOGS AND DERIVATIVES; CATHETER-RELATED INFECTIONS; CROSS INFECTION; GRAM-POSITIVE BACTERIAL INFECTIONS; STATISTICS AND NUMERICAL DATA;

BATHS; CATHETER-RELATED INFECTIONS; CHLORHEXIDINE; CROSS INFECTION; DISINFECTANTS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84959535315     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.11.011     Document Type: Review

References (57)

1. Lee G.M., Kleinman K., Soumerai S.B., Tse A., Cole D., Fridkin S.K., et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 2012, 367:1428-1437.
2. Leikin J.B.P., Frank P. Chlorhexidine Gluconate: Poisoning and toxicology handbook 2008, Informa.
3. Climo M.W., Yokoe D.S., Warren D.K., Perl T.M., Bolon M., Herwaldt L.A., et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013, 368:533-542.
4. Martinez-Resendez M.F., Garza-Gonzalez E., Mendoza-Olazaran S., Herrera-Guerra A., Rodriguez-Lopez J.M., Perez-Rodriguez E., et al. Impact of daily chlorhexidine baths and hand hygiene compliance on nosocomial infection rates in critically ill patients. Am J Infect Control 2014, 42:713-717.
5. Montecalvo M.A., McKenna D., Yarrish R., Mack L., Maguire G., Haas J., et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012, 125:505-511.
6. Evans H.L., Dellit T.H., Chan J., Nathens A.B., Maier R.V., Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010, 145:240-246.
7. Noto M.J., Domenico H.J., Byrne D.W., Talbot T., Rice T.W., Bernard G.R., et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 2015, 313:369-378.
8. Bartlett R.C., Mazens-Sullivan M., Tetreault J.Z., Lobel S., Nivard J. Evolving approaches to management of quality in clinical microbiology. Clin Microbiol Rev 1994, 7:55-88.
9. Wilson M.L. Assuring the quality of clinical microbiology test results. Clin Infect Dis 2008, 47:1077-1082.
10. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
11. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
12. Derde L.P., Cooper B.S., Goossens H., Malhotra-Kumar S., Willems R.J., Gniadkowski M., et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014, 14:31-39.
13. Kim S.Y., Park J.E., Lee Y.J., Seo H.J., Sheen S.S., Hahn S., et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 2013, 66:408-414.
14. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
15. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. BMJ 2003, 326:219.
16. Apisarnthanarak A., Pinitchai U., Warachan B., Warren D.K., Khawcharoenporn T., Hayden M.K. Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai intensive care unit: An analysis before and after extensive flooding. Am J Infect Control 2014, 42:116-121.
17. Sangal V., Girvan E.K., Jadhav S., Lawes T., Robb A., Vali L., et al. Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit in Scotland. Int J Antimicrob Agents 2012, 40:323-331.
18. Traa M.X., Barboza L., Doron S., Snydman D.R., Noubary F., Nasraway S.A. Horizontal infection control strategy decreases methicillin-resistant Staphylococcus aureus infection and eliminates bacteremia in a surgical ICU without active surveillance. Crit Care Med 2014, 42:2151-2157.
19. Munoz-Price L.S., Dezfulian C., Wyckoff M., Lenchus J.D., Rosalsky M., Birnbach D.J., et al. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Crit Care Med 2012, 40:1464-1469.
20. Holder C., Zellinger M. Daily bathing with chlorhexidine in the ICU to prevent central line-associated bloodstream infections. J Clin Outcomes Manag 2009, 16:509-513.
21. Lopez A.C. A quality improvement program combining maximal barrier precaution compliance monitoring and daily chlorhexidine gluconate baths resulting in decreased central line bloodstream infections. Dimens Crit Care Nurs 2011, 30:293-298.
22. Camus C., Salomon S., Bouchigny C., Gacouin A., Lavoue S., Donnio P.Y., et al. Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: A single-center experience. Crit Care Med 2014, 42:1121-1130.
23. Camus C., Bellissant E., Sebille V., Perrotin D., Garo B., Legras A., et al. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med 2005, 33:307-314.
24. Bleasdale S.C., Trick W.E., Gonzalez I.M., Lyles R.D., Hayden M.K., Weinstein R.A. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007, 167:2073-2079.
25. Climo M.W., Sepkowitz K.A., Zuccotti G., Fraser V.J., Warren D.K., Perl T.M., et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37:1858-1865.
26. Popovich K.J., Hota B., Hayes R., Weinstein R.A., Hayden M.K. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009, 30:959-963.
27. Dixon J.M., Carver R.L. Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections. Am J Infect Control 2010, 38:817-821.
28. Popovich K.J., Hota B., Hayes R., Weinstein R.A., Hayden M.K. Daily skin cleansing with chlorhexidine did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit. Intensive Care Med 2010, 36:854-858.
29. Entesari-Tatafi D., Orford N., Bailey M.J., Chonghaile M.N., Lamb-Jenkins J., Athan E. Effectiveness of a care bundle to reduce central line-associated bloodstream infections. Med J Aust 2015, 202:247-249.
30. Gould I.M., MacKenzie F.M., MacLennan G., Pacitti D., Watson E.J., Noble D.W. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. Int J Antimicrob Agents 2007, 29:536-543.
31. Huang S.S., Septimus E., Kleinman K., Moody J., Hickok J., Avery T.R., et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013, 368:2255-2265.
32. Camus C., Sebille V., Legras A., Garo B., Renault A., Le Corre P., et al. Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients. Infection 2014, 42:493-502.
33. Viray M.A., Morley J.C., Coopersmith C.M., Kollef M.H., Fraser V.J., Warren D.K. Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection. Infect Control Hosp Epidemiol 2014, 35:243-250.
34. Petlin A., Schallom M., Prentice D., Sona C., Mantia P., McMullen K., et al. Chlorhexidine gluconate bathing to reduce methicillin-resistant Staphylococcus aureus acquisition. Crit Care Nurse 2014, 34:17-25.
35. Vernon M.O., Hayden M.K., Trick W.E., Hayes R.A., Blom D.W., Weinstein R.A. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006, 166:306-312.
36. O'Horo J.C., Silva G.L., Munoz-Price L.S., Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012, 33:257-267.
37. Derde L.P., Dautzenberg M.J., Bonten M.J. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 2012, 38:931-939.
38. Sievert D., Armola R., Halm M.A. Chlorhexidine gluconate bathing: does it decrease hospital-acquired infections?. Am J Crit Care 2011, 20:166-170.
39. Karki S., Cheng A.C. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect 2012, 82:71-84.
40. Chen W., Li S., Li L., Wu X., Zhang W. Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: a meta-analysis. J Thorac Dis 2013, 5:518-524.
41. Borer A., Gilad J., Porat N., Megrelesvilli R., Saidel-Odes L., Peled N., et al. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect 2007, 67:149-155.
42. Munoz-Price L.S., Hota B., Stemer A., Weinstein R.A. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009, 30:1031-1035.
43. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010, 50:210-217.
44. Raineri E., Crema L., De Silvestri A., Acquarolo A., Albertario F., Carnevale G., et al. Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect 2007, 67:308-315.
45. Pittet D., Angus D.C. Daily chlorhexidine bathing for critically ill patients: a note of caution. JAMA 2015, 313:365-366.
46. van Zanten A.R. Chlorhexidine bathing and infections in critically ill patients. JAMA 2015, 313:1862-1863.
47. Coates T., Bax R., Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 2009, 64:9-15.
48. Watanakunakorn C., Axelson C., Bota B., Stahl C. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect Control 1995, 23:306-309.
49. Ammerlaan H.S., Kluytmans J.A., Wertheim H.F., Nouwen J.L., Bonten M.J. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922-930.
50. van Rijen M., Bonten M., Wenzel R., Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008, Cd006216.
51. Blot K., Bergs J., Vogelaers D., Blot S., Vandijck D. Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis 2014, 59:96-105.
52. Miller S.E., Maragakis L.L. Central line-associated bloodstream infection prevention. Curr Opin Infect Dis 2012, 25:412-422.
53. Calfee D.P. Crisis in hospital-acquired, healthcare-associated infections. Annu Rev Med 2012, 63:359-371.
54. Fraher M.H., Collins C.J., Bourke J., Phelan D., Lynch M. Cost-effectiveness of employing a total parenteral nutrition surveillance nurse for the prevention of catheter-related bloodstream infections. J Hosp Infect 2009, 73:129-134.
55. Coopersmith C.M., Rebmann T.L., Zack J.E., Ward M.R., Corcoran R.M., Schallom M.E., et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002, 30:59-64.
56. Exline M.C., Ali N.A., Zikri N., Mangino J.E., Torrence K., Vermillion B., et al. Beyond the bundle--journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections. Crit Care 2013, 17:R41.
57. Tang H.J., Lin H.L., Lin Y.H., Leung P.O., Chuang Y.C., Lai C.C. The impact of central line insertion bundle on central line-associated bloodstream infection. BMC Infect Dis 2014, 14:356.